Associations of Empagliflozin With Left Ventricular Volumes, Mass, and Function in Patients With Heart Failure and Reduced Ejection Fraction A Substudy of the Empire HF Randomized Clinical Trial
The effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in improving the outcomes associated with heart failure and a reduced ejection fraction (HFrEF) is well established....